Table 2.
Impact of the mass drug administration (MDA) programme (2001–2018) on reducing the lymphatic filariasis burden in the South-East Asia region
| Indicator | W. bancrofti | B. malayi | Total |
|---|---|---|---|
| Number of infections in 2000 | 63 | 7 | 70 |
| Estimated number of infections in 2018 with no MDA in place | 80.4 | 8.6 | 89 |
| Estimated number of total infections in 2018 after MDA impact | 12.4 | 1.5 | 13.9 |
| Estimated number of microfilaraemia cases in 2018 after MDA impact | 1.0 | 0.25 | 1.25 |
| Estimated number of lymphedema cases in 2018 after MDA impact | 6.7 | 1.4 | 8.1 |
| Estimated number of hydrocele cases in 2018 after MDA impact | 5.6 | 0 | 5.6 |
| Estimated number of cases prevented | 68.2 | 6.7 | 74.9 |
| % reduction in cases due to MDA | 84.8 | 77.9 | 84.2 |